The use of urinary sCD163 as a potential biomarker has been investigated in systemic lupus erythematosus (SLE), especially in lupus nephritis [14] another connective tissue disease with a putative role of M2 macrophage. The gene discussed is CD163; the disease is systemic lupus erythematosus.